The authors report on the results of R-DexaBEAM followed by high-dose therapy (HDT). The combination of rituximab with DexaBEAM followed by HDT resulted in high response rates and sustained remissions in responders. R-DexaBEAM followed by HDT can be considered a valid salvage option for NHL.

READ FULL ARTICLE Curated publisher From Mdlinx